3
Announcements
Trials
Browse
Landscape
Status
Completed
2
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Observational
2
Sponsor
Cancer Type
Plasma cell
2
Conditions
Breast Neoplasms
37
Melanoma
17
Prostatic Neoplasms
16
Lung Neoplasms
14
Neoplasms
13
Squamous Cell Carcinoma of Head and Neck
10
Neoplasm Metastasis
9
Carcinoma, Non-Small-Cell Lung
9
Precancerous Conditions
8
Lymphoma
8
Uterine Cervical Neoplasms
6
Pancreatic Neoplasms
6
Leukemia
6
Esophageal Neoplasms
6
Colorectal Neoplasms
6
Colonic Neoplasms
6
Breast Neoplasms, Male
6
Urinary Bladder Neoplasms
5
Rectal Neoplasms
5
Myelodysplastic Syndromes
5
Lymphoma, Follicular
5
Leukemia, Myeloid, Acute
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Head and Neck Neoplasms
5
Barrett Esophagus
5
Adenocarcinoma Of Esophagus
5
Salivary Gland Neoplasms
4
Recurrence
4
Multiple Myeloma
4
Lymphoma, Non-Hodgkin
4
Interventions
Dexamethasone
27
Melphalan
22
Cyclophosphamide
15
Peripheral Blood Stem Cell Transplantation
14
Filgrastim
13
Bortezomib
12
Calcium Dobesilate
9
Lenalidomide
7
fludarabine phosphate
6
Whole-Body Irradiation
5
Mycophenolic Acid
5
Cyclosporine
5
Thalidomide
4
Interferon-alpha
4
Etoposide
4
Busulfan
4
miridesap
3
dexamethasone acetate
3
Radiotherapy
3
Epoetin Alfa
3
Doxycycline
3
Darbepoetin alfa
3
Carboplatin
3
pomalidomide
2
liposomal amphotericin B
2
ixazomib
2
daratumumab
2
birtamimab
2
Thiotepa
2
Tacrolimus
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
Immunoglobulin Light-chain Amyloidosis
×
Biopsy
×
Clear all
NCT03886155
2021-12-22
CAST
The Cleveland Clinic
Completed
107 enrolled
NCT03923920
2021-12-22
ALF
The Cleveland Clinic
Completed
200 enrolled